Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 2/20 | 0.52 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.52 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1861653 | 0.93 | KEAP1 (0.54) | GNAI3GNAO1GNAI1SIGMAR1ALOX15 | |
| SCHEMBL4944738 | 0.91 | GNAI3 (0.63) | GNAI3GNAO1GNAI1DNM1 | |
| SCHEMBL4389217 | 0.91 | GNAI3 (0.57) | GNAI3GNAO1GNAI1SIGMAR1ALOX15 | |
| SCHEMBL6656231 | 0.87 | GNAI3 (0.56) | GNAI3GNAO1GNAI1SIGMAR1 | |
| SCHEMBL1615517 | 0.87 | ALOX15 (0.61) | SIGMAR1ALOX15KEAP1SMN1; SMN2ACE2 | |
| SCHEMBL4666999 | 0.87 | — | — | |
| SCHEMBL6277287 | 0.86 | GNAI3 (0.63) | GNAI3GNAO1GNAI1ALOX15KEAP1 | |
| SCHEMBL856819 | 0.86 | SIGMAR1 (0.48) | GNAI3GNAO1GNAI1SIGMAR1ALOX15 | |
| SCHEMBL6658139 | 0.85 | GNAI3 (0.60) | GNAI3GNAO1GNAI1SIGMAR1 | |
| SCHEMBL16233071 | 0.85 | GNAI3 (0.60) | GNAI3GNAO1GNAI1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | MITSUI CHEMICALS, INC. (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20070054084-A1 | Optical recording medium and compound used for the same | MITSUI CHEMICALS, INC. (JP) | 2007-03-08 | — | — | US | disclosed |
| EP-1672626-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED IN THE OPTICAL RECORDING MEDIUM | Mitsui Chemicals, Inc. (JP) | 2006-06-21 | — | — | EP | disclosed |
| US-4992150-A | Telomer with alpha-olefin;oil and fuel additive | NIPPON OIL CO, LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306376-A1 | OPTICAL RECORDING MEDIUM AND COMPOUND USED FOR THE SAME | CACNA1B, KCNN4, KCNN2 | GNAI3 881/4885GNAO1 191/4885GNAI1 1073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.